Lauren Clarke

Author PubWeight™ 31.39^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Effect of screening and adjuvant therapy on mortality from breast cancer.	N Engl J Med	2005	16.70
2	Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.	J Natl Cancer Inst	2012	2.30
3	Online tool to guide decisions for BRCA1/2 mutation carriers.	J Clin Oncol	2012	1.35
4	An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer.	Genet Med	2003	1.18
5	The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.	J Urol	2005	1.16
6	Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.	Am J Manag Care	2010	1.15
7	Genetic Simulation Resources: a website for the registration and discovery of genetic data simulators.	Bioinformatics	2013	1.01
8	Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.	Pharmacoeconomics	2007	1.00
9	Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis.	Cancer Epidemiol Biomarkers Prev	2005	0.97
10	Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?	Urology	2005	0.95
11	Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.	Stat Methods Med Res	2004	0.92
12	Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan.	J Manag Care Pharm	2006	0.89
13	Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study.	Public Health Genomics	2009	0.88
14	Health care use and primary prophylaxis with colony-stimulating factors.	Value Health	2011	0.80
15	Health insurer policies toward risk-stratified colorectal cancer screening: a survey of health plan medical directors.	J Insur Med	2012	0.76
16	Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.	Pharmacotherapy	2012	0.75